[go: up one dir, main page]

SE9502259L - Oligonukleotider för att inhibera expression av isoprenylproteintransferas - Google Patents

Oligonukleotider för att inhibera expression av isoprenylproteintransferas

Info

Publication number
SE9502259L
SE9502259L SE9502259A SE9502259A SE9502259L SE 9502259 L SE9502259 L SE 9502259L SE 9502259 A SE9502259 A SE 9502259A SE 9502259 A SE9502259 A SE 9502259A SE 9502259 L SE9502259 L SE 9502259L
Authority
SE
Sweden
Prior art keywords
oligonucleotides
protein transferase
inhibit expression
isoprenyl protein
isoprenyl
Prior art date
Application number
SE9502259A
Other languages
English (en)
Swedish (sv)
Other versions
SE9502259D0 (sv
Inventor
Soudhir Colote
Eduardo Pirotzky
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of SE9502259D0 publication Critical patent/SE9502259D0/xx
Publication of SE9502259L publication Critical patent/SE9502259L/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y205/00—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
    • C12Y205/01—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
    • C12Y205/01029—Geranylgeranyl diphosphate synthase (2.5.1.29)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
SE9502259A 1994-06-29 1995-06-21 Oligonukleotider för att inhibera expression av isoprenylproteintransferas SE9502259L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9413035A GB9413035D0 (en) 1994-06-29 1994-06-29 Antisense oligonucleeotides

Publications (2)

Publication Number Publication Date
SE9502259D0 SE9502259D0 (sv) 1995-06-21
SE9502259L true SE9502259L (sv) 1995-12-30

Family

ID=10757497

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9502259A SE9502259L (sv) 1994-06-29 1995-06-21 Oligonukleotider för att inhibera expression av isoprenylproteintransferas

Country Status (25)

Country Link
US (1) US5856461A (sk)
EP (1) EP0692535A1 (sk)
JP (1) JPH0851985A (sk)
KR (1) KR960000914A (sk)
CN (1) CN1124142A (sk)
AU (1) AU689887B2 (sk)
BR (1) BR9503015A (sk)
CA (1) CA2152233A1 (sk)
CZ (1) CZ291496B6 (sk)
DZ (1) DZ1903A1 (sk)
FI (1) FI953170A7 (sk)
FR (2) FR2721930B1 (sk)
GB (2) GB9413035D0 (sk)
HU (1) HU219823B (sk)
IE (1) IE950477A1 (sk)
MA (1) MA23595A1 (sk)
NO (1) NO952601L (sk)
NZ (1) NZ272398A (sk)
OA (1) OA10221A (sk)
PL (1) PL309384A1 (sk)
RU (1) RU2112766C1 (sk)
SE (1) SE9502259L (sk)
SK (1) SK83895A3 (sk)
TN (1) TNSN95068A1 (sk)
ZA (1) ZA955288B (sk)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU724331B2 (en) * 1995-07-13 2000-09-14 University Of Cincinnati, The Compounds useful in the treatment of neurofibromatosis
CN1301731A (zh) * 1999-12-24 2001-07-04 上海博德基因开发有限公司 一种新的多肽——多异戊二烯基合成酶蛋白9和编码这种多肽的多核苷酸
AU2002230651A1 (en) * 2000-12-07 2002-06-18 Bristol-Myers Squibb Company Human g-protein coupled receptor expressed highly in kidney
RU2224524C2 (ru) * 2002-03-29 2004-02-27 Некоммерческое партнерство "АСГЛ - Исследовательские лаборатории" Олигонуклеотиды для подавления жизнедеятельности патогенных микроорганизмов и способ подавления их жизнедеятельности
US20030212017A1 (en) * 2002-05-10 2003-11-13 Isis Pharmaceuticals Inc. Antisense modulation of farnesyl transferase beta subunit expression
US7507808B2 (en) * 2002-12-12 2009-03-24 Isis Pharmaceuticals, Inc. Modulation of endothelial lipase expression
SI3342425T1 (sl) 2003-09-09 2020-04-30 Geron Corporation Modificirani oligonukleotidi za inhibicijo telomeraze
US8785409B2 (en) 2007-01-30 2014-07-22 Geron Corporation Compounds having anti-adhesive effects on cancer cells
JOP20200257A1 (ar) 2014-05-01 2017-06-16 Geron Corp تركيبات أوليجو نوكليوتيد وطرق لتحضيرها

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4571421A (en) * 1979-11-05 1986-02-18 Genentech, Inc. Mammalian gene for microbial expression
US5004803A (en) * 1988-11-14 1991-04-02 Genetics Institute, Inc. Production of procoagulant proteins
US5420245A (en) * 1990-04-18 1995-05-30 Board Of Regents, The University Of Texas Tetrapeptide-based inhibitors of farnesyl transferase
US5185248A (en) * 1990-05-08 1993-02-09 E. R. Squibb & Sons, Inc. Farnesyl-protein transferase assay for identifying compounds that block neoplastic transformation
KR100242671B1 (ko) * 1991-03-07 2000-03-02 고돈 에릭 유전학적으로 처리한 백신 균주
NZ244820A (en) * 1991-10-25 1994-01-26 Isis Pharmaceuticals Inc Oligonucleotide inhibitor of epstein-barr virus.
US5348853A (en) * 1991-12-16 1994-09-20 Biotronics Corporation Method for reducing non-specific priming in DNA amplification
US5585479A (en) * 1992-07-24 1996-12-17 The United States Of America As Represented By The Secretary Of The Navy Antisense oligonucleotides directed against human ELAM-I RNA

Also Published As

Publication number Publication date
GB2290791B (en) 1998-08-05
EP0692535A1 (fr) 1996-01-17
US5856461A (en) 1999-01-05
DZ1903A1 (fr) 2002-02-17
GB2290791A (en) 1996-01-10
FI953170L (fi) 1995-12-30
HU219823B (hu) 2001-08-28
JPH0851985A (ja) 1996-02-27
TNSN95068A1 (fr) 1996-02-06
IE950477A1 (en) 1996-01-10
CN1124142A (zh) 1996-06-12
FI953170A7 (fi) 1995-12-30
AU2329995A (en) 1996-01-11
RU2112766C1 (ru) 1998-06-10
MA23595A1 (fr) 1995-12-31
FI953170A0 (fi) 1995-06-27
BR9503015A (pt) 1996-06-04
FR2721930A1 (fr) 1996-01-05
AU689887B2 (en) 1998-04-09
NO952601D0 (no) 1995-06-28
SE9502259D0 (sv) 1995-06-21
SK83895A3 (en) 1996-05-08
CZ291496B6 (cs) 2003-03-12
GB9513246D0 (en) 1995-09-06
OA10221A (fr) 1997-09-19
PL309384A1 (en) 1996-01-08
RU95110774A (ru) 1997-04-20
GB9413035D0 (en) 1994-08-17
FR2721930B1 (fr) 1997-01-03
CZ168895A3 (en) 1996-05-15
FR2721827A1 (fr) 1996-01-05
ZA955288B (en) 1996-01-31
HU9501913D0 (en) 1995-08-28
KR960000914A (ko) 1996-01-25
NZ272398A (en) 1996-04-26
CA2152233A1 (en) 1995-12-30
HUT72133A (en) 1996-03-28
NO952601L (no) 1996-01-02

Similar Documents

Publication Publication Date Title
ES2154624T1 (es) Regulacion de la expresion de la quinolato fosforribosil transferasa.
EP1250455A4 (en) ANTISENSE INHIBITION OF PTP1B EXPRESSION.
NO985427L (no) Modulatorer for vevsregenerering
FI951612A0 (fi) Menetelmiä synteettisten oligonukleotidien sekvensoimiseksi, jotka sisältävät nukleotidien välisiä ei-fosfodiesterisidoksia
EP1417351A4 (en) ANTISENSE MODULATION OF THE EXPRESSION OF APOLIPOPROTEIN (A)
DE69940785D1 (de) Proteinexpressionsvektor und benutzung desselbigen
EP1569695A4 (en) ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION
WO2002036743A3 (en) Antisense modulation of calreticulin expression
CY1110982T1 (el) Συνθεσεις και μεθοδοι για την αυξηση της ασβεστοποιησεως των οστων
NO985804D0 (no) DNA-sekvens som koder fystase av mikroorganismer
NO983716D0 (no) Metoksyetoksy oligonukleotider for modulering av protein-kinase C ekspresjon
JP2001515920A5 (sk)
HRP20010036B1 (hr) Neurotrofni faktor rasta
DK1123414T3 (da) Antisense-modulering af integrin alpha 4.ekspression
ATE190352T1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
SE9502259L (sv) Oligonukleotider för att inhibera expression av isoprenylproteintransferas
WO2000029623A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
EP1131107A4 (en) ANTISENSE MODULATION OF THE EXPRESSION OF INHIBITOR-KAPPA-B-KINASE-ALPHA
DK0775745T3 (da) Cathepsin G-inhiberende aptamerer
FR2663033B1 (fr) Detection specifique du mycobacterium tuberculosis.
WO2003008545A3 (en) Antisense modulation of glioma-associated oncogene-2 expression
WO1999014337A3 (en) New plant genes
DE50110597D1 (de) L-Aminosäure-Oxidase aus Rhodococcus-Arten
DE69402201D1 (de) Phosphorhaltiges, metallurgisches silizium zur herstellung von organohalosilanen
EP1165145A4 (en) ANTISENSE MODULATION OF THE MDMX EXPRESSION

Legal Events

Date Code Title Description
NAV Patent application has lapsed